Preparation and characterization of DOX loaded keratin nanoparticles for pH/GSH dual responsive release

Materials Science and Engineering C

Volumn 73, Issue , 2017, Pages 189-197

  Li, Yanmei ^a   Zhi, Xuelian ^a   Lin, Jiantao ^b   You, Xin ^a   Yuan, Jiang ^a  

^a NANJING NORMAL UNIVERSITY   (China)

^b GUANGDONG MEDICAL UNIVERSITY   (China)

Author keywords

Doxorubicin; Keratin; Nitric oxide; Stimuli sensitive drug delivery

Indexed keywords

CROSSLINKING; DYNAMIC LIGHT SCATTERING; KERATIN; LIGHT SCATTERING; MEDICINE; MOLECULAR BIOLOGY; NANOPARTICLES; NITRIC OXIDE; TUMORS;

CHEMICAL CROSS-LINKING; DOXORUBICIN; DRUG DELIVERY APPLICATIONS; DRUG LOADED NANOPARTICLE; ENHANCED PERMEABILITY AND RETENTION EFFECTS; RESPONSIVE CHARACTERS; SCAN ELECTRONIC MICROSCOPES; STIMULI-SENSITIVE;

CONTROLLED DRUG DELIVERY;

DOXORUBICIN; GLUTATHIONE; KERATIN; NANOPARTICLE; NITRIC OXIDE;

A-549 CELL LINE; ANIMAL; CELL DEATH; CELL SURVIVAL; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG EFFECTS; DRUG RELEASE; ENDOCYTOSIS; HEMOLYSIS; HUMAN; KINETICS; METABOLISM; MOUSE; NIH 3T3 CELL LINE; PARTICLE SIZE; PH; PHOTON CORRELATION SPECTROSCOPY; RABBITS AND HARES; STATIC ELECTRICITY; ULTRASTRUCTURE;

A549 CELLS; ANIMALS; CELL DEATH; CELL SURVIVAL; DOXORUBICIN; DRUG DELIVERY SYSTEMS; DRUG LIBERATION; DYNAMIC LIGHT SCATTERING; ENDOCYTOSIS; GLUTATHIONE; HEMOLYSIS; HUMANS; HYDROGEN-ION CONCENTRATION; KERATINS; KINETICS; MICE; NANOPARTICLES; NIH 3T3 CELLS; NITRIC OXIDE; PARTICLE SIZE; RABBITS; STATIC ELECTRICITY;

EID: 85006915665     PISSN: 09284931     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.msec.2016.12.067     Document Type: Article

References (57)

1. [1] Siegel, R., Naishadham, D., Jemal, A., Cancer statistics 2012. CA Cancer J. Clin. 62 (2012), 10–29.
2. [2] Tseng, C.L., Su, W.Y., Yen, K.C., Yang, K.C., Lin, F.H., The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation. Biomaterials 30:20 (2009), 3476–3485.
3. [3] Huang, L., Tao, K., Liu, J., Qi, C., Xu, L., Chang, P., Gao, J., Shuai, X., Wang, G., Wang, Z., Wang, L., Design and fabrication of multifunctional sericin nanoparticles for tumor targeting and pH-responsive subcellular delivery of cancer chemotherapy drugs. ACS Appl. Mater. Interfaces 8:10 (2016), 6577–6585.
4. [4] Feng, S.S., Chien, S., Chemotherapeutic engineering: application and further development of chemical engineering principles for chemotherapy of cancer and other diseases. Chem. Eng. Sci. 58:18 (2003), 4087–4114.
5. [5] Kalyanaraman, B., Joseph, J., Kalivendi, S.S., Wang, S.W., Konorev, E., Kotamraju, S., Doxorubicin-induced apoptosis: implications in cardiotoxicity. Mol. Cell. Biochem. 234:37 (2002), 119–124.
6. [6] Yuba, E., Harada, A., Sakanishi, Y., Kono, K., Carboxylated hyperbranched poly(glycidol)s for preparation of pH-sensitive liposomes. J. Control. Release 149:1 (2011), 72–80.
7. [7] Leite, E.A., dos Santos Giuberti, C., Wainstein, A.J., Wainstein, A.P.D., Coelho, L.G., Lana, Â.M., Savassi-Rocha, P.R., De Oliveira, M.C., Acute toxicity of long-circulating and pH-sensitive liposomes containing cisplatin in mice after intraperitoneal administration. Life Sci. 84:19–20 (2009), 641–649.
8. [8] Liu, J., Li, H.X., Jiang, X.Q., Zhang, C., Ping, Q., Novel pH-sensitive chitosan-derived micelles loaded with paclitaxel. Carbohydr. Polym. 82:2 (2010), 432–439.
9. [9] Kim, J.H., Li, Y., Kim, M.S., Kang, S.W., Jeong, J.H., Lee, D.S., Synthesis and evaluation of biotin-conjugated pH-responsive polymeric micelles as drug carriers. Int. J. Pharm. 427:2 (2012), 435–442.
10. [10] Prajakta, D., Ratnesh, J., Chandan, K., Suresh, S., Grace, S., Meera, V., Vandana, P., Curcumin loaded pH-sensitive nanoparticles for the treatment of colon cancer. J. Biomed. Nanotechnol. 5 (2009), 445–455.
11. [11] Makhlof, A., Tozuka, Y., Takeuchi, H., Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery. Eur. J. Pharm. Sci. 42:5 (2011), 445–451.
12. [12] Zhang, X., Achazi, K., Haag, R., Boronate cross-linked ATP-and pH-responsive nanogels for intracellular delivery of anticancer drugs. Adv. Healthc. Mater., 4(4), 2015, 585.
13. [13] Yallapu, M.M., Jaggi, M., Chauhan, S.C., Design and engineering of nanogels for cancer treatment. Drug Discov. Today 16:9–10 (2011), 457–463.
14. [14] Yao, X.M., Chen, L.X.F., Xie, Z.G., Ding, J.X., He, C.L., Zhang, J.P., Chen, X.S., pH-Responsive metallo-supramolecular nanogel for synergistic chemo-photodynamic therapy. Acta Biomater. 25:1 (2015), 162–171.
15. [15] Brigger, I., Dubernet, C., Couvreur, P., Nanoparticles in cancer therapy and diagnosis. Adv. Drug Deliv. Rev. 54:5 (2002), 631–651.
16. [16] Langer, R., Drug delivery and targeting. Nature 392 (1998), 5–10.
17. [17] Dang, J.M., Leong, K.W., Natural polymers for gene delivery and tissue engineering. Adv. Drug Deliv. Rev. 58:4 (2006), 487–499.
18. [18] Elzoghby, A.O., Gelatin-based nanoparticles as drug and gene delivery systems: reviewing three decades of research. J. Control. Release 172 (2013), 1075–1091.
19. [19] MaHam, A.H., Tang, Z.W., Wu, H., Wang, J., Lin, Y.H., Protein-based nanomedicine platforms for drug delivery. Small 5:15 (2009), 1706–1721.
20. [20] Wongpinyochit, T., Uhlmann, P., Urquhart, A.J., Seib, F.P., PEGylated silk nanoparticles for anticancer drug delivery. Biomacromolecules 16 (2015), 3712–3722.
21. [21] Fraser, R.D., MacRae, T.P., Parry, D.A., Suzuki, E., Intermediate filaments in alpha-keratins. Proc. Natl. Acad. Sci. U. S. A. 83 (1986), 1179–1183.
22. [22] Moll, R., Divo, M., Langbein, L., The human keratins: biology and pathology. Histochem. Cell Biol. 129 (2008), 705–733.
23. [23] Yu, J., Yu, D., Checkla, M., Freedberg, I.M., Bertolino, A.P., Human hair keratins. J. Invest. Dermatol. 101 (1993), 56S–59S.
24. [24] Saul, J.M., Ellenburg, M.D., de Guzman, R.C., Dyke, M.V., Keratin hydrogels support the sustained release of bioactive ciprofloxacin. J. Biomed. Mater. Res. A 98A (2011), 544–553.
25. [25] Guo, J.H., Pan, S.J., Yin, X.C., He, Y.F., Li, T., Wang, R.M., pH-sensitive keratin-based polymer hydrogel and its controllable drug-release behavior. J. Appl. Polym. Sci., 132, 2015, 41572.
26. [26] Yin, X.C., Li, F.Y., He, Y.F., Wang, Y., Wang, R.M., Study on effective extraction of chicken feather keratins and their films for controlling drug release. Biomater. Sci. 1 (2013), 528–536.
27. [27] Li, Q.M., Zhu, L.J., Liu, R.G., Huang, D., Jin, X., Che, N., Li, Z., Qu, X.Z., Kang, H.L., Huang, Y., Biological stimuli responsive drug carriers based on keratin for triggerable drug delivery. J. Mater. Chem. 22 (2012), 19964–19973.
28. [28] Li, Q.M., Yang, S.N., Zhu, L.J., Kang, H.L., Qu, X.Z., Liu, R.G., Huang, Y., Dual-stimuli sensitive keratin graft PHPMA as physiological trigger responsive drug carriers. Polym. Chem. 6 (2015), 2869–2878.
29. [29] Kamaly, N., Yameen, B., Wu, J., Farokhzad, O.C., Degradable controlled-release polymers and polymeric nanoparticles: mechanisms of controlling drug release. Chem. Rev. 116:4 (2016), 2602–2663.
30. [30] Sun, Q.H., Radosz, M., Shen, Y.Q., Challenges in design of translational nanocarriers. J. Control. Release 164:2 (2012), 156–169.
31. [31] Gao, W.W., Chan, J.M., Farokhzad, O.C., pH-responsive nanoparticles for drug delivery. Mol. Pharm. 7:6 (2010), 1913–1920.
32. [32] Meng, F.H., Zhong, Z.Y., Feijen, J., Stimuli-responsive polymersomes for programmed drug delivery. Biomacromolecules 10:2 (2009), 197–209.
33. [33] Storp, B.V., Engel, A., Boeker, A., Ploeger, M., Langer, K., Albumin nanoparticles with predictable size by desolvation procedure. J. Microencapsul. 29:2 (2012), 138–146.
34. [34] Lin, W., Coombes, A., Davies, M., Davis, S., Illum, L., Preparation of sub-100 nm human serum albumin nanospheres using a pH-coacervation method. J. Drug Target. 1:3 (1993), 237–243.
35. [35] Cui, W., Wang, A., Zhao, J., Yang, X., Cai, P., Li, J., Layer by layer assembly of albumin nanoparticles with selective recognition of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). J. Colloid Interface Sci. 465 (2016), 11–17.
36. [36] Yuan, J., Geng, J., Xing, Z., Shim, K.J., Han, I., Kim, J.C., Kang, I.K., Shen, J., Novel wound dressing based on nanofibrous PHBV–keratin mats. J. Tissue Eng. Regen. Med. 9:9 (2015), 1027–1035.
37. [37] Yamauchi, K., Yamauchi, A., Kusunoki, T., Kohda, A., Konishi, Y., Preparation of stable aqueous solution of keratins, and physiochemical and biodegradational properties of films. J. Biomed. Mater. Res. 31:4 (1996), 439–444.
38. [38] Schrooyen, P.M.M., Dijkstra, P.J., Oberthür, R.C., Bantjes, A., Feijen, J., Partially carboxymethylated feather keratins. 1. Properties in aqueous systems. J. Agric. Food Chem. 48:9 (2000), 4326–4334.
39. [39] Jin, X.X., Wang, Y.F., Yuan, J., Shen, J., Extraction, characterization, and NO release potential of keratin from human hair. Mater. Lett. 175:15 (2016), 188–190.
40. [40] Yuan, J., Shen, J., Kang, I.K., Fabrication of protein-doped PLA composite nanofibrous scaffolds for tissue engineering. Polym. Int. 57:10 (2008), 1188–1193.
41. [41] Rahimnejad, M., Mokhtarian, N., Ghasemi, M., Production of protein nanoparticles for food and drug delivery system. Afr. J. Biotechnol. 8:19 (2009), 4738–4743.
42. [42] Jun, J.Y., Nguyen, H.H., Paik, S.Y.R., Chun, H.S., Kang, B.C., Ko, S., Preparation of size-controlled bovine serum albumin (BSA) nanoparticles by a modified desolvation method. Food Chem. 127 (2011), 1892–1898.
43. [43] Wang, J., Wu, W., Zhang, Y.J., Wang, X., Qian, H.Q., Liu, B.R., Jiang, X.Q., The combined effects of size and surface chemistry on the accumulation of boronic acid-rich protein nanoparticles in tumors. Biomaterials 35 (2014), 866–878.
44. [44] Xie, L.L., Tong, W.J., Yu, D.H., Xu, J.Q., Li, J., Gao, C.Y., Bovine serum albumin nanoparticles modified with multilayers and aptamers for pH-responsive and targeted anti-cancer drug delivery. J. Mater. Chem. 22 (2012), 6053–6060.
45. [45] Varga, N., Benkő, M., Sebők, D., Dékány, I., BSA/polyelectrolyte core–shell nanoparticles for controlled release of encapsulated ibuprofen. Colloids Surf., B 123:1 (2014), 616–622.
46. [46] Das, S., Subuddhi, U., Cyclodextrin mediated controlled release of naproxen from ph-sensitive chitosan/poly(vinyl alcohol) hydrogels for colon targeted delivery. Ind. Eng. Chem. Res. 52:39 (2013), 14192–14200.
47. [47] Wu, L.Y., Zhang, L.P., Shi, G., Ni, C.H., Zwitterionic pH/redox nanoparticles based on dextran as drug carriers for enhancing tumor intercellular uptake of doxorubicin. Mater. Sci. Eng. C 61 (2016), 278–285.
48. [48] Li, N.N., Lin, J.T., Gao, D., Zhang, L.M., A macromolecular prodrug strategy for combinatorial drug delivery. J. Colloid Interface Sci. 417 (2014), 301–309.
49. [49] Li, N.N., Zhang, P., Huang, C.Z., Song, Y.M., Garg, S., Luan, Y.X., Co-delivery of doxorubicin hydrochloride and verapamil hydrochloride by pH-sensitive polymersomes for the reversal of multidrug resistance. RSC Adv. 5 (2015), 77986–77995.
50. [50] Hart, T.W., Some observations concerning the S-nitroso and S-phenylsulphonyl derivatives of L-cysteine and glutathione. Tetrahedron Lett. 26 (1985), 2013–2016.
51. [51] Turnbull, C.M., Cena, C., Fruttero, R., Gasco, A., Rossi, A.G., Megson, I.L., Mechanism of action of novel NO-releasing furoxan derivatives of aspirin in human platelets. Brit. J. Pharmacol. 148:4 (2006), 517–526.
52. [52] Green, L.C., Wagner, D.A., Glogowski, J., Skipper, P.L., Wishnok, J.S., Tannenbaum, S.R., Analysis of nitrate, nitrite, and nitrate in biological fluids. Anal. Biochem. 126:1 (1982), 131–138.
53. [53] Feelisch, M., Schönafinger, K., Noack, E., Thiol-mediated generation of nitric oxide accounts for the vasodilator action of furoxans. Biochem. Pharmacol. 44:6 (1992), 1149–1157.
54. [54] Ferioli, R., Folco, G.C., Ferretti, C., Gasco, A.M., Medana, C., Fruttero, R., Civelli, M., Gasco, A., A new class of furoxan derivatives as NO donors: mechanism of action and biological activity. Brit. J. Pharmacol. 114:4 (1995), 816–820.
55. [55] Xu, H., Yang, D., Cai, C., Gou, J., Zhang, Y., Wang, L., Zhong, H., Tang, X., Dual-responsive mPEG-PLGA-PGlu hybrid-core nanoparticles with a high drug loading to reverse the multidrug resistance of breast cancer: an in vitro and in vivo evaluation. Acta Biomater. 16 (2015), 156–168.
56. [56] Ishima, Y., Chen, D., Fang, J., Maeda, H., Minomo, A., Kragh-Hansen, U., Kai, T., Maruyama, T., Otagiri, M., S-nitrosated human serum albumin dimer is not only a novel anti-tumor drug but also a potentiator for anti-tumor drugs with augmented EPR effects. Bioconjug. Chem. 23 (2012), 264–271.
57. [57] Lee, H.J., Kim, D.E., Park, D.J., Choi, G.H., Yang, D.N., Heo, J.S., Lee, S.C., pH-Responsive mineralized nanoparticles as stable nanocarriers for intracellular nitric oxide delivery. Colloid. Surf. B 146:1 (2016), 1–8.